OPEN END-TURBO-OPTIONSSCHEIN - INCYTE CO. | Market Closed - BOERSE MUENCHEN 15:36:43 2024-06-28 EDT | ||
| 0.95 EUR | -9.52% |
|
| Current month | +31.94% | ||
| 1 month | +39.71% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
INCYTE CORPORATION
Latest news about INCYTE CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-06-28 | 0.95 | -9.52% |
| 24-06-27 | 1.05 | -4.55% |
| 24-06-26 | 1.1 | -11.29% |
| 24-06-25 | 1.24 | -3.13% |
| 24-06-24 | 1.28 | +4.07% |
Real-time BOERSE MUENCHEN
Last update June 28, 2024 at 03:36 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | INCYTE CORPORATION |
| Issuer | HSBC |
| WKN | HG98J0 |
| ISIN | DE000HG98J09 |
| Date issued | 2023-05-05 |
| Strike | 50.35 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.18 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2 € |
|---|---|
| Lowest since issue | 0.19 € |
Company Profile
Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows:
- product sales (85.6%);
- royalties (14.2%);
- income from research and cooperation agreements (0.2%).
Sector
-
Consensus: Incyte Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
60.62
USD
Average target price
72.8
USD
Spread / Average Target
+20.09%
- Stock Market
- Certificates
- Certificat
